Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Scientific Reports|October 10, 2019
Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastomaTakahiro Sasaki, Manabu Kinoshita, Koji Fujita, et al.
Scientific Reports|August 8, 2018
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomasHideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi, et al.
Journal of Neuro-Oncology|August 5, 2018
Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS TumorsTakahiro Sasaki, Junya Fukai, Yoshinori Kodama, et al.
Plos One|December 3, 2020
Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasionTakamune Achiha, Noriyuki Kijima, Yoshinori Kodama, et al.
Neuro-Oncology Practice|November 12, 2016
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis†Motomasa Furuse, Naosuke Nonoguchi, Toshihiko Kuroiwa, et al.
Scientific Reports|January 1, 2020
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural networkRyohei Fukuma, Takufumi Yanagisawa, Manabu Kinoshita, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
NPJ Digital Medicine|May 5, 2026
Comparing artificial intelligence and physician performance in predicting IDH mutation status in gliomaSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Acta Neuropathologica Communications|August 10, 2016
A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomasHideyuki Arita, Kai Yamasaki, Yuko Matsushita, et al.
Acta Neuropathologica Communications|December 6, 2018
Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumorsKohei Fukuoka, Yonehiro Kanemura, Tomoko Shofuda, et al.
Pageof 8